Abbott Labs (ABT) PT Lowered at RBC Capital Amid 'Challenging Year-End'
Tweet Send to a Friend
RBC Capital analyst Shagun Singh lowered the price target on Abbott Labs (NYSE: ABT) to $135.00 (from $147.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
